Sale!

TGFBR1 Gene Aortic Aneurysm Familial Thoracic Type 5 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “TGFBR1 Gene Aortic Aneurysm Familial Thoracic Type 5 Genetic Test” is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the TGFBR1 gene that are linked to Aortic Aneurysm Familial Thoracic Type 5. This condition is a genetic disorder that predisposes individuals to thoracic aortic aneurysms and dissections, which can lead to life-threatening complications if not diagnosed and managed appropriately. The test, priced at 4400 AED, provides crucial information for the early detection and management of this condition, allowing for timely intervention and personalized treatment plans. By analyzing the specific genetic makeup of the TGFBR1 gene, healthcare professionals can better understand the risk factors associated with the development of thoracic aortic aneurysms in affected families, enabling them to implement preventive measures and monitor the condition closely.

Description

TGFBR1 Gene Aortic Aneurysm Familial Thoracic Type 5 Genetic Test

Test Name: TGFBR1 Gene Aortic Aneurysm Familial Thoracic Type 5 Genetic Test

Components: TGFBR1 Gene Aortic Aneurysm Familial Thoracic Type 5 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Vascular Diseases

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for TGFBR1 Gene Aortic Aneurysm, Familial Thoracic Type 5 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TGFBR1 Gene Aortic Aneurysm, Familial Thoracic Type 5 NGS Genetic DNA Test gene TGFBR1.

Test Details: The TGFBR1 gene is associated with a condition called familial thoracic aortic aneurysm type 5 (FTAAD5). This is a genetic disorder characterized by the weakening and enlargement of the aorta, which is the main blood vessel that carries oxygen-rich blood from the heart to the rest of the body.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes, including the TGFBR1 gene, to identify any genetic variations or mutations that may be associated with a specific condition or disease. In the case of FTAAD5, NGS genetic testing can be used to identify any mutations in the TGFBR1 gene that may be causing the development of thoracic aortic aneurysms in an individual or their family members.

This type of genetic testing can provide valuable information about an individual’s risk of developing thoracic aortic aneurysms and can help guide medical management and treatment options. It can also be used for genetic counseling and family planning purposes.

Test Name	TGFBR1 Gene Aortic aneurysm familial thoracic type 5 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Vascular Diseases
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for TGFBR1 Gene Aortic aneurysm, familial thoracic type 5 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TGFBR1 Gene Aortic aneurysm, familial thoracic type 5 NGS Genetic DNA Test gene TGFBR1
Test Details	The TGFBR1 gene is associated with a condition called familial thoracic aortic aneurysm type 5 (FTAAD5). This is a genetic disorder characterized by the weakening and enlargement of the aorta, which is the main blood vessel that carries oxygen-rich blood from the heart to the rest of the body. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes, including the TGFBR1 gene, to identify any genetic variations or mutations that may be associated with a specific condition or disease. In the case of FTAAD5, NGS genetic testing can be used to identify any mutations in the TGFBR1 gene that may be causing the development of thoracic aortic aneurysms in an individual or their family members. This type of genetic testing can provide valuable information about an individual’s risk of developing thoracic aortic aneurysms and can help guide medical management and treatment options. It can also be used for genetic counseling and family planning purposes.